- Home
- PCRX vs FRPH Comparison
PCRX vs FRPH Comparison
Compare PCRX & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- FRPH
- Stock Information
- Founded
- PCRX 2006
- FRPH 1986
- Country
- PCRX United States
- FRPH United States
- Employees
- PCRX N/A
- FRPH N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- FRPH Real Estate
- Sector
- PCRX Health Care
- FRPH Finance
- Exchange
- PCRX Nasdaq
- FRPH Nasdaq
- Market Cap
- PCRX 604.7M
- FRPH 608.6M
- IPO Year
- PCRX 2011
- FRPH N/A
- Fundamental
- Price
- PCRX $22.36
- FRPH $30.44
- Analyst Decision
- PCRX Buy
- FRPH
- Analyst Count
- PCRX 10
- FRPH 0
- Target Price
- PCRX $27.60
- FRPH N/A
- AVG Volume (30 Days)
- PCRX 810.1K
- FRPH 26.3K
- Earning Date
- PCRX 02-27-2025
- FRPH 03-05-2025
- Dividend Yield
- PCRX N/A
- FRPH N/A
- EPS Growth
- PCRX N/A
- FRPH 45.62
- EPS
- PCRX N/A
- FRPH 0.40
- Revenue
- PCRX $694,957,000.00
- FRPH $31,414,000.00
- Revenue This Year
- PCRX $4.83
- FRPH N/A
- Revenue Next Year
- PCRX $2.16
- FRPH N/A
- P/E Ratio
- PCRX N/A
- FRPH $76.12
- Revenue Growth
- PCRX 4.40
- FRPH 4.04
- 52 Week Low
- PCRX $11.16
- FRPH $26.99
- 52 Week High
- PCRX $34.01
- FRPH $33.00
- Technical
- Relative Strength Index (RSI)
- PCRX 70.92
- FRPH 52.47
- Support Level
- PCRX $18.18
- FRPH $28.58
- Resistance Level
- PCRX $22.36
- FRPH $30.02
- Average True Range (ATR)
- PCRX 1.13
- FRPH 0.66
- MACD
- PCRX 0.30
- FRPH 0.09
- Stochastic Oscillator
- PCRX 93.11
- FRPH 83.78
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).